• Fewer PSA screenings linked to increases in advanced prostate cancer diagnoses

    One year ago - By Healio

    U.S. states with larger declines in PSA screening from 2002 to 2016 also had larger increases in incidence of metastatic prostate cancer at diagnosis, according to a presentation at Genitourinary Cancers Symposium.
    “Our data strengthen the epidemiologic evidence supporting that the rise in metastatic prostate cancer at diagnosis may at least in part be explained by the decline in PSA screening, since states with larger declines in PSA screening tended to have larger increases in metastatic disease at diagnosis,” Vidit Sharma, MD, health services fellow in urologic oncology at
    Read more ...